Investment Rating - The investment rating for the company is "Buy" and is maintained [7] Core Insights - In 2025, the company achieved a revenue of 8.21 billion yuan, a year-on-year decline of 7.23%, and a net profit attributable to shareholders of 1.18 billion yuan, down 3.85%. However, the net profit excluding non-recurring items reached 0.21 billion yuan, marking a significant year-on-year increase of 78.41% [2][5] - For Q4 2025, the company reported a revenue of 2.63 billion yuan, a decline of 1.60% year-on-year, with a net profit of -0.06 billion yuan, down 124.46%. The net profit excluding non-recurring items was 0.19 billion yuan, indicating a turnaround from losses [2][5] - The company plans to distribute a cash dividend of 1.5 yuan per 10 shares (tax included) to all shareholders [2][5] - The company has proposed a 2026 employee stock ownership plan, covering senior management and key personnel, with a total fund not exceeding 200 million yuan [2][5] Financial Performance Summary - The company's overall revenue growth was stable in the domestic market, while external sales were impacted. In 2025, domestic revenue grew by 2.04% year-on-year, while external sales fell by 48.83% [10] - The overall gross margin improved, leading to an increase in the net profit margin excluding non-recurring items. The gross margin for the year increased by 1.27 percentage points, with domestic and external gross margins at 29.02% and 6.59%, respectively [10] - The company expects net profits attributable to shareholders for 2026, 2027, and 2028 to be 0.28 billion, 0.33 billion, and 0.35 billion yuan, respectively, with corresponding PE ratios of 27.42, 23.35, and 21.65 times [10]

Investment Rating - The report maintains an "Accumulate" rating for Jiuyang Co., Ltd. (002242.SZ) with a current price of 9.57 yuan [1]. Core Insights - Jiuyang Co., Ltd. reported a total revenue of 8.2 billion yuan for 2025, a year-on-year decrease of 7.2%, and a net profit attributable to shareholders of 120 million yuan, down 3.9% year-on-year [5][6]. - The company’s domestic revenue grew by 2.0% to 7.4 billion yuan, while overseas revenue fell by 48.8% to 800 million yuan due to tariff policies and operational adjustments [6]. - The company has focused on high-end, health-oriented, and smart product innovations, leveraging space technology for product development [7]. Summary by Sections Financial Performance - In Q4 2025, Jiuyang achieved a revenue of 2.6 billion yuan, with a quarter-on-quarter increase of 64.2% but a year-on-year decline of 1.6% [5]. - The company’s gross margin improved to 26.8%, but the net profit margin for Q4 was -0.2%, with an annual net profit margin of 1.4%, indicating a historically low level [6]. Product Development and Market Strategy - Jiuyang launched several innovative products, including the K7Pro soy milk maker and the B1U variable frequency blender, emphasizing low purine and noise reduction features [7]. - The company has shifted some markets from self-operated to authorized distribution to mitigate risks associated with overseas sales [6]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders has been revised down to 240 million yuan for 2026 and 280 million yuan for 2027, reflecting a decrease of 22% and 15% respectively from previous estimates [8]. - The projected P/E ratios for 2026, 2027, and 2028 are 31, 26, and 23 times respectively, maintaining a solid market position in core product categories [8][9].

Investment Rating - The investment rating for the company is "Outperform" [6] Core Insights - The company's performance in 2025 was below expectations, with revenue of 8.21 billion yuan, a year-on-year decline of 7%, and a net profit attributable to shareholders of 118 million yuan, down 4% year-on-year. However, the non-recurring net profit increased by 78% [6] - The company has launched a 2026 employee stock ownership plan aiming to raise up to 200 million yuan [6] - Domestic sales showed growth, with total domestic revenue reaching 7.39 billion yuan, a year-on-year increase of 2.04%, while external sales fell by 48.83% [6] - The company effectively managed costs, with sales expenses down by 7.61% and R&D expenses down by 16.07% [6] - The earnings forecast for 2026 has been adjusted to 265 million yuan, reflecting a significant increase of 124.9% year-on-year, with a projected PE ratio of 28 [6] Financial Data Summary - Total revenue for 2025 was 82.10 billion yuan, with a net profit of 1.18 billion yuan [5] - The company’s gross margin is projected to be 27.0% in 2026, with a return on equity (ROE) of 7.4% [5] - The company’s total assets and liabilities ratio stands at 53.76% as of December 31, 2025 [5]

Investment Rating - The investment rating for the company is "Outperform" [6] Core Insights - The company's performance in 2025 was below expectations, with revenue of 8.21 billion yuan, a year-on-year decline of 7%, and a net profit attributable to shareholders of 118 million yuan, down 4% year-on-year. However, the non-recurring net profit increased by 78% [6] - The company has launched a 2026 employee stock ownership plan aiming to raise up to 200 million yuan, indicating a focus on long-term growth and employee engagement [6] - Domestic sales showed growth, with a total revenue of 73.85 billion yuan, up 2.04% year-on-year, while external sales fell by 48.83% [6] - The company is effectively managing costs, with a 7.61% decrease in sales expenses and a 16.07% reduction in R&D investment [6] - Profit forecasts for 2026 and 2027 have been adjusted to 265 million yuan and 306 million yuan respectively, reflecting a significant recovery in profitability [6] Financial Data Summary - Total revenue projections for 2026 are estimated at 8.41 billion yuan, with a year-on-year growth rate of 2.5% [5] - The gross profit margin is expected to be 27.0% in 2026, with a return on equity (ROE) of 7.4% [5] - The price-to-earnings (PE) ratio is projected to be 28 for 2026, decreasing to 24 in 2027 and 23 in 2028 [5]

Investment Rating - The report maintains a "Buy" rating for the company [4][7]. Core Views - The company reported a significant increase in non-recurring net profit, with a 78.4% year-on-year growth in 2025, despite a 7.2% decline in total revenue [1][4]. - The company has a high dividend payout ratio of 97.29%, indicating a commitment to returning value to shareholders [4]. Financial Performance Summary - **Revenue and Profit**: In 2025, the company achieved a revenue of 8.21 billion yuan, down 7.2% year-on-year, and a net profit attributable to shareholders of 120 million yuan, down 3.8% year-on-year. The non-recurring net profit was 210 million yuan, up 78.4% year-on-year [1][6]. - **Quarterly Performance**: In Q4 2025, the company reported a revenue of 2.62 billion yuan, a decrease of 1.6% year-on-year, and a net profit of -10 million yuan, down 124.5% year-on-year, with a non-recurring net profit of 20 million yuan, up 268.2% year-on-year [1][3]. - **Product Segmentation**: Revenue from food processing machines, nutrition pots, Western appliances, and cookware was 3.10 billion, 3.06 billion, 1.53 billion, and 330 million yuan respectively, with year-on-year changes of +3.6%, -15.6%, -9.5%, and +5.3% [2]. - **Regional Performance**: Domestic and foreign revenue was 7.38 billion and 830 million yuan respectively, with year-on-year changes of +2.0% and -48.8% [2]. Profitability Metrics - **Gross Margin**: The gross margin improved to 26.8% for 2025, up 1.3 percentage points year-on-year, with Q4 gross margin at 26.5%, up 2.7 percentage points year-on-year [3]. - **Net Margin**: The net margin for 2025 was 1.4%, an increase of 0.2 percentage points year-on-year, while Q4 net margin was -0.2%, down 0.8 percentage points year-on-year [3]. - **Expense Ratios**: In 2025, the sales, management, R&D, and financial expense ratios were 17.0%, 4.6%, 3.7%, and -0.9% respectively, with slight variations compared to the previous year [3]. Future Earnings Forecast - The company is expected to recover gradually, with projected net profits for 2026, 2027, and 2028 at 145 million, 155 million, and 164 million yuan, representing year-on-year growth of 23.5%, 6.8%, and 5.9% respectively [4][6].

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 10.00 RMB [6]. Core Views - The company reported a revenue of 8.21 billion RMB in 2025, a year-on-year decrease of 7.23%, and a net profit attributable to shareholders of 118 million RMB, down 3.85% year-on-year. However, the non-recurring net profit increased by 78.41% to 212 million RMB [1]. - Despite short-term profit pressures, the long-term recovery trend remains intact, driven by product structure optimization and potential growth in domestic demand policies [1][2]. - The company experienced a significant decline in overseas sales, with a 48.83% drop to 825 million RMB, primarily due to increased tariffs in the U.S. Domestic sales grew modestly by 2.04% to 7.39 billion RMB [2]. Summary by Sections Financial Performance - The company's gross margin improved to 26.77%, up 1.27 percentage points year-on-year, attributed to product structure optimization. The sales expense ratio was 16.95%, a slight decrease of 0.07 percentage points [3]. - The company faced fair value losses of 123 million RMB and foreign exchange losses, impacting overall profit performance [3]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders for 2026 and 2027 is adjusted to 307 million RMB and 376 million RMB, respectively, with an expected EPS of 0.40 RMB for 2026 [4]. - The company is valued at a PE ratio of 25 times for 2026, maintaining a target price of 10 RMB [4].

九阳股份有限公司 2026 年员工持股计划管理办法 二〇二六年三月 1 第一章 总则 第一条 为规范九阳股份有限公司（以下简称"九阳股份"或"公司"）2026 年员工持股计划（以下简称"员工持股计划"、"本员工持股计划"）的实施，根据 《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、《关于上市公司实施员工持股计划试点的指导意见》 （以下简称"《指导意见》"）、《深圳证券交易所上市公司自律监管指引第 1 号— —主板上市公司规范运作》（以下简称"《自律监管指引》"）等相关法律、行政法 规、规章、规范性文件和《公司章程》之规定，特制定本管理办法。 第二章 员工持股计划的制定 第二条 员工持股计划所遵循的基本原则 （一）依法合规原则 公司实施本员工持股计划，严格按照法律、行政法规的规定履行程序，真实、 准确、完整、及时地实施信息披露。任何人不得利用本员工持股计划进行内幕交 易、操纵证券市场等证券欺诈行为。 （二）自愿参与原则 公司实施本员工持股计划遵循公司自主决定，员工自愿参加的原则，公司不 以摊派、强行分配等方式强制员工参加本员工持股计划。 （三）风险自担 ...

国浩律师（上海）事务所 关 于 九阳股份有限公司 2026 年员工持股计划（草案） 之 法律意见书 上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编：200085 25-28th Floor, Suhe Centre, 99 North Shanxi Road, Shanghai 200085, China 电话/Tel: +86 21 5234 1668 传真/Fax: +86 21 5243 3320 网址/Website: http://www.grandall.com.cn 2026 年 3 月 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于九阳股份有限公司 2026 年员工持股计划（草案）之 法律意见书 致：九阳股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受九阳股份有限公司（以下 简称"九阳股份"或"公司"）的委托，担任公司 2026 年员工持股计划（以下简称"本 次员工持股计划"）的特聘专项法律顾问。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、中国证券监督管理委员会（以下简 称 ...

九阳股份有限公司 2026 年员工持股计划（草案） 证券简称：九阳股份 证券代码：002242 九阳股份有限公司 2026 年员工持股计划（草案） 二〇二六年三月 1 九阳股份有限公司 2026 年员工持股计划（草案） 声明 本公司及董事会全体成员保证本员工持股计划及其摘要内容的真实、准确和 完整，没有虚假记载、误导性陈述或重大遗漏。 2 九阳股份有限公司 2026 年员工持股计划（草案） 风险提示 一、九阳股份有限公司（以下简称"九阳股份""公司"或"本公司"）2026 年员工持股计划（草案）（以下简称"本员工持股计划草案"）须经公司股东会 批准后方可实施，本员工持股计划草案能否获得公司股东会批准，存在不确定性。 二、有关公司 2026 年员工持股计划（以下简称"本员工持股计划"）的 具体的资金来源、出资金额、预计规模和具体实施方案等属初步结果，能否 完成实施，存在不确定性。 三、若员工认购资金较低，本员工持股计划存在无法成立的风险；若员 工认购份额不足，本员工持股计划存在低于预计规模的风险。 四、股票价格受公司经营业绩、宏观经济周期、国际/国内政治经济形势 及投资者心理等多种复杂因素影响。因此，股票交易是 ...

九阳股份有限公司 关于公司及控股子公司利用闲置自有资金购买理财产品的公告 证券代码：002242 证券简称：九阳股份 公告编号：2026-004 3、投资期限：自股东会审议通过之日起一年内有效。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示： 1、投资种类：主要包括现金类理财产品、固定收益类产品、国债逆回购等 安全性高、流动性好的短期低风险理财产品，投资期限原则上不超过 1 年。上述 投资不涉及股票及其衍生产品、证券投资基金、以证券投资为目的的委托理财产 品及其他与证券相关的投资； 2、投资金额：不超过人民币十亿元（含）的闲置自有资金。在上述额度内， 资金可以滚动使用，期限内任一时点的交易金额（含前述投资的收益进行再投资 的相关金额）不超过投资额度。 3、特别风险提示：尽管投资的理财产品属于短期低风险投资品种，但金融 市场受宏观经济的影响较大，不排除该项投资受到市场波动的影响；九阳股份有 限公司（以下简称：公司）将根据生产经营资金冗余的变化适时适量的介入，且 投资品类存在浮动收益的可能，实际收益不可预期；相关工作人员存在违规操作 和监督失控的风 ...